NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional) - RFA-RM-25-002
Funder
National Institutes of Health
LOI Required
No
Application Deadline
Maximum Project Duration
5 years
Research Focus Areas
New
Public Health Campaigns
Behavioral and Systems
Clinical
Description
The NIH Director’s New Innovator Award supports early stage investigators of exceptional creativity who propose bold and highly innovative research projects with the potential to produce a major impact on broad, important areas relevant to the mission of NIH. Applications in all topics relevant to the broad mission of NIH are welcome, including, but not limited to, behavioral, social, biomedical, applied, and formal sciences and topics that may involve basic, translational, or clinical research. The NIH Director's New Innovator Award complements other ongoing efforts by NIH and its Institutes and Centers to fund early-stage investigators. The NIH Director’s New Innovator Award is a component of the High-Risk, High-Reward Research (HRHR) Program of the NIH Common Fund.